LY294002
| Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
|---|---|---|---|---|---|
| HY-10108-5MG | 5 mg | 66,00 | 42,90 | Add | |
| HY-10108-10MG | 10 mg | 93,00 | 60,50 | Add | |
| HY-10108-1ML | 10mM/1mL | 101,00 | 65,70 | Add | |
| HY-10108-50MG | 50 mg | 126,00 | 81,90 | Add | |
| HY-10108-100MG | 100 mg | 158,00 | 102,70 | Add | |
| HY-10108-200MG | 200 mg | 221,00 | 143,70 | Add | |
| HY-10108-500MG | 500 mg | 468,00 | 304,20 | Add | |
| HY-10108-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Promotion runs until 31.12.2024Year-End Promotion : 35% discount on the entire MedChem Express portfolio
LY294002 is a broad-spectrum inhibitor of PI3K with IC50s of 0.5, 0.57, and 0.97 μM for PI3Kα, PI3Kδ and PI3Kβ, respectively[1]. LY294002 also inhibits CK2 with an IC50 of 98 nM[2]. LY294002 is a competitive DNA-PK inhibitor that binds reversibly to the kinase domain of DNA-PK with an IC50 of 1.4?μM. LY294002 is an apoptosis activator[3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer; Infection |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic);Ethanol : 50 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 1 |
| Purity | 99.95% |
| Molecular Formula | C19H17NO3 |
| Molecular Weight | 307.34 |
| CAS-Number | 154447-36-6 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
